Homre Ltd approves ₹12.50 crore preferential warrant issue

2 min read     Updated on 19 Aug 2026, 05:15 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Homre Limited approved a ₹12.50 crore preferential issue of fully convertible warrants and a new ESOP scheme covering 3 crore options. The warrant issuance involves eight investors, significantly altering the post-conversion shareholding structure. Both proposals require shareholder approval at the upcoming AGM.

powered bylight_fuzz_icon
48685525

*this image is generated using AI for illustrative purposes only.

Homre Limited approved a preferential issue of fully convertible warrants (FCWs) worth up to ₹12.50 crore during its board meeting held on August 19, 2026. The issuance is structured as a private placement under Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. Each warrant will be convertible into one equity share of the company.

The board also approved the introduction of the HOMRE ESOP 2026 scheme, which covers up to 3 crore employee stock options. These options are convertible into one equity share each with a face value of ₹1. The exercise price and vesting schedule will be determined by the Nomination and Remuneration Committee in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Warrant Issuance Details

The FCW issue involves eight investors, comprising both promoter and non-promoter groups. The post-issue shareholding pattern assumes full conversion of the warrants based on the issue price determined with reference to August 25, 2026.

Investor Category Pre-Issue Shares Post-Issue Shares Pre-Issue % Post-Issue %
M/s Supriya Securities Pvt. Ltd. (Promoter) 16,10,600 2,16,10,600 0.81% 8.45%
M/s Ganpati Warehousing Limited (Non-Promoter) 1,21,234 3,01,21,234 0.06% 11.78%
Mrs. Mamuni Agrawal (Individual) 37,971 25,37,971 0.02% 0.99%
Mr. Dipesh Kumar Chauhan (Individual) 154,000 6,54,000 0.08% 0.26%

Other non-promoter investors include Mrs. Kusha Dipeshkumar Chauhan, Dipeshkumar Valamjibhai Chauhan HUF, Mrs. Krutika Divyesh Chauhan, and Mr. Divyesh Valamjibhai Chauhan. Their holdings are projected to increase from less than 0.25% individually to between 0.24% and 0.51% post-conversion.

Key Terms and Conditions

Warrant holders may exercise their rights in one or more tranches within 18 months from the date of allotment. Unexercised warrants will lapse after this period, and the subscription amount will be forfeited as per SEBI ICDR Regulations. The issue price is determined in accordance with applicable provisions with reference to the relevant date.

Both the preferential issue and the ESOP scheme are subject to shareholder approval and other statutory regulatory approvals. The company has scheduled its 36th Annual General Meeting for September 24, 2026, to be conducted via Video Conferencing or Other Audio Visual Means.

Administrative Appointments

The board appointed M/s. Datt Ganesh & Associates as Secretarial Auditor for FY26-27 and M/s. S. Lal & Company as Internal Auditor for the same financial year. Mr. Ajay Kumar Choudhary was appointed as Scrutinizer for the upcoming AGM e-voting process. The Register of Members and Share Transfer Books will remain closed from September 19, 2026, to September 24, 2026.

Historical Stock Returns for HOMRE

1 Day5 Days1 Month6 Months1 Year5 Years
+1.54%+5.32%-2.94%+42.45%+224.59%+518.75%

How might the significant increase in promoter and non-promoter shareholding post-warrant conversion impact Homre Limited's corporate governance and decision-making dynamics?

What specific strategic initiatives or capital expenditures is Homre Limited likely funding with the ₹12.50 crore raised through the FCW issuance?

Given the 18-month exercise window for warrants, how could market volatility between August 2026 and early 2028 influence investor sentiment and potential dilution levels?

Homre Ltd board to approve ESOP 2026 and preferential warrants

2 min read     Updated on 11 Aug 2026, 08:16 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Homre Limited's board meets on August 19, 2026, to approve the ESOP 2026 scheme and a preferential issue of fully convertible warrants. Both measures require shareholder approval and compliance with SEBI regulations. The company, formerly Triton Corp Limited, disclosed the agenda via BSE intimation.

powered bylight_fuzz_icon
48005190

*this image is generated using AI for illustrative purposes only.

Homre Limited, formerly known as Triton Corp Limited, has scheduled a meeting of its Board of Directors for Wednesday, August 19, 2026, to consider significant corporate actions including the introduction of a new employee incentive scheme and a capital raising measure. The board will deliberate on the implementation of the Homre Limited Employee Stock Option Plan – ESOP 2026, based on recommendations from the Nomination and Remuneration Committee. Additionally, the board will review a proposal for the preferential issue and allotment of Fully Convertible Warrants, which are convertible into equity shares of the company. These warrants are intended for identified persons belonging to the Promoter and/or Non-Promoter categories. Both the ESOP scheme and the warrant issue require subsequent approval from the company's shareholders.

The proceedings are governed by Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates prior intimation of board meetings. The company disclosed these agenda items in a notice dated August 11, 2026, addressed to the Listing Department of BSE Limited. The preferential issue of warrants must comply with the provisions of the Companies Act, 2013, and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, along with other applicable laws. Any statutory or regulatory approvals required for these transactions will be sought prior to implementation.

Agenda Items

The board meeting will address the following key resolutions:

Agenda Item Details Approval Required
ESOP Scheme Introduction of Homre Limited Employee Stock Option Plan – ESOP 2026 Shareholders
Capital Issue Preferential allotment of Fully Convertible Warrants Shareholders & Regulatory
AGM Notice Approval of notice convening the Annual General Meeting Board

The introduction of the ESOP 2026 aims to align employee interests with shareholder value through equity-based incentives. The specific terms, quantum, and eligibility criteria for the stock options will be detailed in the final scheme document presented to shareholders. Similarly, the pricing, conversion ratio, and identity of the subscribers for the Fully Convertible Warrants will be determined in accordance with regulatory guidelines and disclosed upon finalization.

Corporate Governance and Compliance

Bharat Singh Bisht, Whole-Time Director of Homre Limited, signed the disclosure letter. The company’s ISIN code is INE982C01033, and it is listed on the Bombay Stock Exchange under Scrip Code 523387. The board will also consider the notice convening the Annual General Meeting of the company during this session. Other business may be transacted with the permission of the Chair, as permitted under standard corporate governance practices. Investors are advised to monitor subsequent filings for the final resolutions passed by the board and the details of the shareholder vote.

Historical Stock Returns for HOMRE

1 Day5 Days1 Month6 Months1 Year5 Years
+1.54%+5.32%-2.94%+42.45%+224.59%+518.75%

How might the dilution from the Fully Convertible Warrants impact existing shareholder equity and earnings per share in the near term?

What specific performance metrics or vesting schedules are likely to be included in the ESOP 2026 to ensure long-term employee retention?

Could the preferential allotment of warrants to promoter or non-promoter categories signal a strategic partnership or significant capital injection for upcoming projects?

More News on HOMRE

1 Year Returns:+224.59%